Skip to content

Non-pharmacological interventions for dyspnoea in lung cancer patients

Evaluating the effectiveness of a patient education program which includes breathing exercises and psychosocial support for helping patients with lung cancer to control their dyspnoea.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000087459
Enrollment
144
Registered
2007-01-25
Start date
2008-03-13
Completion date
2011-01-13
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study aims to test the effectivenss of a patient education program whixch includes breathing exercises and psychosocial support for helping patients with lung cancer to control their dyspnoea. The study will test whether the intervention reduces a patient's feelings of breathlessness, improves their ability to funtion and minimises their emotional distress and in addition the study will examine the effectiveness over time. The information gained will provide more specific guidance to practitioners for targeting intervention approaches to each individual patient's needs.

Interventions

The enhanced non-pharmacological intervention group (ENPT) experience a 60 minute educational session on management of dyspnoea run by a registered nurse. Patients are then followed up with weekly phone calls for 3 weeks. The instruction is supplemented with a range of resources to reinforce intervention delivery and promote self managment.

Sponsors

Queensland University of Technology
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Diagnosis: Patients diagnosed with small cell or non-small cell lung cancer; have completed first line therapy for their disease; have an average dyspnoea rating of >2 on 11 point numeric rating scale in the past week; have an aniticipated life expectancy of at least 3 months.

Exclusion criteria

Exclusion criteria:Demonstrated cognitive impairment that would prevent them from responding to a survey questionniare; have a life expectancy of less than 3 mths.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 17, 2026